ALEMBIC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEMBIC, and what generic and branded alternatives to ALEMBIC drugs are available?
ALEMBIC has one hundred and seventy-four approved drugs.
There are eleven tentative approvals on ALEMBIC drugs.
Summary for ALEMBIC
US Patents: | 0 |
Tradenames: | 136 |
Ingredients: | 135 |
NDAs: | 174 |
Patent Litigation for ALEMBIC: | See patent lawsuits for ALEMBIC |
PTAB Cases with ALEMBIC as petitioner: | See PTAB cases with ALEMBIC as petitioner |
Drugs and US Patents for ALEMBIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic | CANDESARTAN CILEXETIL | candesartan cilexetil | TABLET;ORAL | 209119-001 | Jun 20, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Alembic | ACYCLOVIR | acyclovir | CREAM;TOPICAL | 212361-001 | Nov 21, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Alembic | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 213248-003 | May 13, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.